Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

v3.21.1
Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Equity [Abstract]      
Capital stock authorized 260,000,000    
Common stock, authorized 250,000,000   250,000,000
Common stock, par value (in dollars per share) $ 0.001   $ 0.001
Preferred stock, authorized 10,000,000   10,000,000
Preferred stock, par value (in dollars per share) $ 0.001   $ 0.001
Share-based compensation expense for options $ 42,171 $ 33,048  
Total unrecognized compensation expense $ 221,939    
Weighted average period expected to recognized compensation expense (in years) 3 months    
Series A Preferred Stock Dividend Rate 10.00%    
Accrued dividends $ 154,556 $ 154,556  
Stock option exercise 2,500    
Proceed from stock option exercise $ 5,400